Percutaneous coronary intervention delayed or elective PCI in patients with STEMI

Jump to navigation Jump to search

Percutaneous Coronary Intervention Guidelines Microchapters

Home

Patient Information

Overview

PCI Approaches:

CAD Revascularization:

Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Intervention in left main coronary artery disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization

Pre-procedural Considerations:

Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup

Procedural Considerations:

Vascular Access
PCI in Specific Clinical Situations:
Asymptomatic Ischemia or CCS Class I or II Angina
CCS Class III Angina
Unstable Angina/Non–ST-Elevation Myocardial Infarction
ST-Elevation Myocardial Infarction:
General and Specific Considerations
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
Cardiogenic Shock
Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet therapy:
Oral Antiplatelet Therapy
Glycoprotein IIb/IIIa Receptor Antagonists
Intravenous Antiplatelet therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices

Post-Procedural Considerations:

Post-procedural Antiplatelet Therapy
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis
Exercise Testing
Cardiac Rehabilitation

Quality and Performance Considerations:

Quality and Performance
Certification and Maintenance of Certification
Operator and Institutional Competency and Volume

Percutaneous coronary intervention delayed or elective PCI in patients with STEMI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Percutaneous coronary intervention delayed or elective PCI in patients with STEMI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Percutaneous coronary intervention delayed or elective PCI in patients with STEMI

CDC on Percutaneous coronary intervention delayed or elective PCI in patients with STEMI

Percutaneous coronary intervention delayed or elective PCI in patients with STEMI in the news

Blogs on Percutaneous coronary intervention delayed or elective PCI in patients with STEMI

Directions to Hospitals Treating Percutaneous Coronary Intervention

Risk calculators and risk factors for Percutaneous coronary intervention delayed or elective PCI in patients with STEMI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention (DO NOT EDIT)[1]

Delayed or Elective PCI in Patients with STEMI (DO NOT EDIT)[1]

Class III (No Benefit)

"1. PCI of a totally occluded infarct artery greater than 24 hours after STEMI should not be performed in asymptomatic patients with 1- or 2-vessel disease if patients are hemodynamically and electrically stable and do not have evidence of severe ischemia.[2][3][4] (Level of Evidence: B)"

Class IIa

"1. PCI is reasonable in patients with STEMI and clinical evidence for fibrinolytic failure or infarct artery reocclusion.[5][6] (Level of Evidence: B)"

"2. PCI is reasonable in patients with STEMI and a patent infarct artery 3 to 24 hours after fibrinolytic therapy.[7][8] (Level of Evidence: B)"

"3. PCI is reasonable in patients with STEMI who demonstrate ischemia on noninvasive testing.[9][10] (Level of Evidence: B)"

Class IIb

"1. PCI of a hemodynamically significant stenosis in a patent infarct artery greater than 24 hours after STEMI may be considered as part of an invasive strategy.[11][12][13][14][15](Level of Evidence: B)"

References

  1. 1.0 1.1 Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter |month= ignored (help)
  2. Ioannidis JP, Katritsis DG (2007). "Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients". American Heart Journal. 154 (6): 1065–71. doi:10.1016/j.ahj.2007.07.049. PMID 18035076. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  3. Steg PG, Thuaire C, Himbert D, Carrié D, Champagne S, Coisne D, Khalifé K, Cazaux P, Logeart D, Slama M, Spaulding C, Cohen A, Tirouvanziam A, Montély JM, Rodriguez RM, Garbarz E, Wijns W, Durand-Zaleski I, Porcher R, Brucker L, Chevret S, Chastang C (2004). "DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction". European Heart Journal. 25 (24): 2187–94. doi:10.1016/j.ehj.2004.10.019. PMID 15589635. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  4. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL (2006). "Coronary intervention for persistent occlusion after myocardial infarction". The New England Journal of Medicine. 355 (23): 2395–407. doi:10.1056/NEJMoa066139. PMC 1995554. PMID 17105759. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  5. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de Belder A, Davis J, Pitt M, Banning A, Baumbach A, Shiu MF, Schofield P, Dawkins KD, Henderson RA, Oldroyd KG, Wilcox R (2005). "Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction". The New England Journal of Medicine. 353 (26): 2758–68. doi:10.1056/NEJMoa050849. PMID 16382062. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  6. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, Foody JM, Krumholz HM, Phillips CO, Kashani A, You JJ, Tu JV, Ko DT (2007). "Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials". Journal of the American College of Cardiology. 49 (4): 422–30. doi:10.1016/j.jacc.2006.09.033. PMID 17258087. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  7. Borgia F, Goodman SG, Halvorsen S, Cantor WJ, Piscione F, Le May MR, Fernández-Avilés F, Sánchez PL, Dimopoulos K, Scheller B, Armstrong PW, Di Mario C (2010). "Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis". European Heart Journal. 31 (17): 2156–69. doi:10.1093/eurheartj/ehq204. PMID 20601393. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  8. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG (2009). "Routine early angioplasty after fibrinolysis for acute myocardial infarction". The New England Journal of Medicine. 360 (26): 2705–18. doi:10.1056/NEJMoa0808276. PMID 19553646. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  9. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, Dubach P, Resink TJ, Pfisterer M (2007). "Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial". JAMA : the Journal of the American Medical Association. 297 (18): 1985–91. doi:10.1001/jama.297.18.1985. PMID 17488963. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  10. Madsen JK, Grande P, Saunamäki K, Thayssen P, Kassis E, Eriksen U, Rasmussen K, Haunsø S, Nielsen TT, Haghfelt T, Fritz-Hansen P, Hjelms E, Paulsen PK, Alstrup P, Arendrup H, Niebuhr-Jørgensen U, Andersen LI (1997). "Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction". Circulation. 96 (3): 748–55. PMID 9264478. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  11. Stenestrand U, Wallentin L (2002). "Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study". Lancet. 359 (9320): 1805–11. doi:10.1016/S0140-6736(02)08710-X. PMID 12044375. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  12. Alter DA, Tu JV, Austin PC, Naylor CD (2003). "Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada". Journal of the American College of Cardiology. 42 (3): 410–9. PMID 12906964. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  13. Zeymer U, Uebis R, Vogt A, Glunz HG, Vöhringer HF, Harmjanz D, Neuhaus KL (2003). "Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte". Circulation. 108 (11): 1324–8. doi:10.1161/01.CIR.0000087605.09362.0E. PMID 12939210. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  14. Gupta M, Chang WC, Van de Werf F, Granger CB, Midodzi W, Barbash G, Pehrson K, Oto A, Toutouzas P, Jansky P, Armstrong PW (2003). "International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2". European Heart Journal. 24 (18): 1640–50. PMID 14499226. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)
  15. Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, Giugliano RP, Antman EM, Braunwald E (2003). "Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials". Journal of the American College of Cardiology. 42 (1): 7–16. PMID 12849652. Retrieved 2011-12-08. Unknown parameter |month= ignored (help)

Template:WH Template:WS